Peter Mikael Helweg Heegaard

Peter Mikael Helweg Heegaard

Auto-generated profile, based on publicly available information

Peter Mikael Helweg Heegaard

Department of Health Technology, Technical University of Denmark, Kgs. Lyngby 2800, Denmark

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2004 in Veterinary Research
Verified
Journal Article
Open access
PDF file
HPHenrik Hagbard Petersen
Henrik Hagbard Petersen
JNJens Peter Nielsen
Jens Peter Nielsen
PHPeter Mikael Helweg Heegaard
Peter Mikael Helweg Heegaard
The body's early defence in response to trauma, inflammation or infection, the acute phase response, is a complex set of systemic reactions seen shortly after exposure to a triggering event. One of the many components is an acute phase protein response in which increased hepatic synthesis leads to increased serum concentration of positive acute phase proteins. The serum concentration of these acute phase proteins returns to base levels when the triggering factor is no longer present. This paper provides a review of the acute phase proteins haptoglobin, C-reactive protein and serum amyloid A and their possible use as non-specific indicators of health in large animal veterinary medicine such as in the health status surveillance of pigs at the herd level, for the detection of mastitis in dairy cattle and for the prognosis of respiratory diseases in horses.

1 November 2000 in Veterinary Immunology and Immunopathology
Verified
Journal Article
Closed access
PHPeter M.H Heegaard
Peter M.H Heegaard
DGDale L Godson
Dale L Godson
MTMathilda J.M Toussaint
Mathilda J.M Toussaint
KTKirsten Tjørnehøj
Kirsten Tjørnehøj
LLlars Larsen
lars Larsen
LRLeif Rønsholt
Leif Rønsholt

1 February 1998 in Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
PHPeter M.H Heegaard
Peter M.H Heegaard
JKJoan Klausen
Joan Klausen
JNJens Peter Nielsen
Jens Peter Nielsen
NGNieves González-Ramón
Nieves González-Ramón
MPMatilde Piñeiro
Matilde Piñeiro
MAMaria A Alava
Maria A Alava

1 May 2009 in Veterinary Microbiology
Verified
Journal Article
Closed access
ØAØystein Angen
Øystein Angen
JTJohn Thomsen
John Thomsen
LLlars Larsen
lars Larsen
JLJesper Larsen
Jesper Larsen
BKBranko Kokotovic
Branko Kokotovic
JEJörg M.D. Enemark
Jörg M.D. Enemark

5 February 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SBSharon Brookes
Sharon Brookes
ANAlejandro Núñez
Alejandro Núñez
BCBhudipa Choudhury
Bhudipa Choudhury
MMMikhail Matrosovich
Mikhail Matrosovich
SEStephen C. Essen
Stephen C. Essen
IBIan H. Brown
Ian H. Brown
The declaration of the human influenza A pandemic (H1N1) 2009 (H1N1/09) raised important questions, including origin and host range [1], [2]. Two of the three pandemics in the last century resulted in the spread of virus to pigs (H1N1, 1918; H3N2, 1968) with subsequent independent establishment and evolution within swine worldwide [3]. A key public and veterinary health consideration in the context of the evolving pandemic is whether the H1N1/09 virus could become established in pig populations [4]. We performed an infection and transmission study in pigs with A/California/07/09. In combination, clinical, pathological, modified influenza A matrix gene real time RT-PCR and viral genomic analyses have shown that infection results in the induction of clinical signs, viral pathogenesis restricted to the respiratory tract, infection dynamics consistent with endemic strains of influenza A in pigs, virus transmissibility between pigs and virus-host adaptation events. Our results demonstrate that extant H1N1/09 is fully capable of becoming established in global pig populations. We also show the roles of viral receptor specificity in both transmission and tissue tropism. Remarkably, following direct inoculation of pigs with virus quasispecies differing by amino acid substitutions in the haemagglutinin receptor-binding site, only virus with aspartic acid at position 225 (225D) was detected in nasal secretions of contact infected pigs. In contrast, in lower respiratory tract samples from directly inoculated pigs, with clearly demonstrable pulmonary pathology, there was apparent selection of a virus variant with glycine (225G). These findings provide potential clues to the existence and biological significance of viral receptor-binding variants with 225D and 225G during the 1918 pandemic [5].

4 November 2009 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
PHPeter M. H. Heegaard
Peter M. H. Heegaard
UBUlrik Boas
Ulrik Boas
NSNanna Skall Sorensen
Nanna Skall Sorensen